Cargando…

AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration

Advanced glycation end-products (AGEs; e.g., glyoxal, methylglyoxal or carboxymethyl-lysine) are heterogenous group of toxic compounds synthesized in the body through both exogenous and endogenous pathways. AGEs are known to covalently modify proteins bringing about loss of functional alteration in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Reshmee, Alam, Mohammad Rizwan, Kamal, Mohammad Azhar, Seo, Kyung Jin, Singh, Laishram Rajendrakumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230046/
https://www.ncbi.nlm.nih.gov/pubmed/37266370
http://dx.doi.org/10.3389/fnmol.2023.1155175
_version_ 1785051426263662592
author Bhattacharya, Reshmee
Alam, Mohammad Rizwan
Kamal, Mohammad Azhar
Seo, Kyung Jin
Singh, Laishram Rajendrakumar
author_facet Bhattacharya, Reshmee
Alam, Mohammad Rizwan
Kamal, Mohammad Azhar
Seo, Kyung Jin
Singh, Laishram Rajendrakumar
author_sort Bhattacharya, Reshmee
collection PubMed
description Advanced glycation end-products (AGEs; e.g., glyoxal, methylglyoxal or carboxymethyl-lysine) are heterogenous group of toxic compounds synthesized in the body through both exogenous and endogenous pathways. AGEs are known to covalently modify proteins bringing about loss of functional alteration in the proteins. AGEs also interact with their receptor, receptor for AGE (RAGE) and such interactions influence different biological processes including oxidative stress and apoptosis. Previously, AGE-RAGE axis has long been considered to be the maligning factor for various human diseases including, diabetes, obesity, cardiovascular, aging, etc. Recent developments have revealed the involvement of AGE-RAGE axis in different pathological consequences associated with the onset of neurodegeneration including, disruption of blood brain barrier, neuroinflammation, remodeling of extracellular matrix, dysregulation of polyol pathway and antioxidant enzymes, etc. In the present article, we attempted to describe a new avenue that AGE-RAGE axis culminates to different pathological consequences in brain and therefore, is a central instigating component to several neurodegenerative diseases (NGDs). We also invoke that specific inhibitors of TIR domains of TLR or RAGE receptors are crucial molecules for the therapeutic intervention of NGDs. Clinical perspectives have also been appropriately discussed.
format Online
Article
Text
id pubmed-10230046
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102300462023-06-01 AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration Bhattacharya, Reshmee Alam, Mohammad Rizwan Kamal, Mohammad Azhar Seo, Kyung Jin Singh, Laishram Rajendrakumar Front Mol Neurosci Molecular Neuroscience Advanced glycation end-products (AGEs; e.g., glyoxal, methylglyoxal or carboxymethyl-lysine) are heterogenous group of toxic compounds synthesized in the body through both exogenous and endogenous pathways. AGEs are known to covalently modify proteins bringing about loss of functional alteration in the proteins. AGEs also interact with their receptor, receptor for AGE (RAGE) and such interactions influence different biological processes including oxidative stress and apoptosis. Previously, AGE-RAGE axis has long been considered to be the maligning factor for various human diseases including, diabetes, obesity, cardiovascular, aging, etc. Recent developments have revealed the involvement of AGE-RAGE axis in different pathological consequences associated with the onset of neurodegeneration including, disruption of blood brain barrier, neuroinflammation, remodeling of extracellular matrix, dysregulation of polyol pathway and antioxidant enzymes, etc. In the present article, we attempted to describe a new avenue that AGE-RAGE axis culminates to different pathological consequences in brain and therefore, is a central instigating component to several neurodegenerative diseases (NGDs). We also invoke that specific inhibitors of TIR domains of TLR or RAGE receptors are crucial molecules for the therapeutic intervention of NGDs. Clinical perspectives have also been appropriately discussed. Frontiers Media S.A. 2023-05-17 /pmc/articles/PMC10230046/ /pubmed/37266370 http://dx.doi.org/10.3389/fnmol.2023.1155175 Text en Copyright © 2023 Bhattacharya, Alam, Kamal, Seo and Singh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Neuroscience
Bhattacharya, Reshmee
Alam, Mohammad Rizwan
Kamal, Mohammad Azhar
Seo, Kyung Jin
Singh, Laishram Rajendrakumar
AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration
title AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration
title_full AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration
title_fullStr AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration
title_full_unstemmed AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration
title_short AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration
title_sort age-rage axis culminates into multiple pathogenic processes: a central road to neurodegeneration
topic Molecular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230046/
https://www.ncbi.nlm.nih.gov/pubmed/37266370
http://dx.doi.org/10.3389/fnmol.2023.1155175
work_keys_str_mv AT bhattacharyareshmee agerageaxisculminatesintomultiplepathogenicprocessesacentralroadtoneurodegeneration
AT alammohammadrizwan agerageaxisculminatesintomultiplepathogenicprocessesacentralroadtoneurodegeneration
AT kamalmohammadazhar agerageaxisculminatesintomultiplepathogenicprocessesacentralroadtoneurodegeneration
AT seokyungjin agerageaxisculminatesintomultiplepathogenicprocessesacentralroadtoneurodegeneration
AT singhlaishramrajendrakumar agerageaxisculminatesintomultiplepathogenicprocessesacentralroadtoneurodegeneration